Haig P. Bozigian Insider Trading for August 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Haig P. Bozigian.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Haig P. Bozigian for August 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 8.66 | 2,726 | 23,607 | 80,000 | |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 8.66 | 17,274 | 149,593 | 82,726 | |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 8.66 | 2,726 | 23,607 | 80,000 | |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 5.76 | 5,071 | 29,209 | 100,000 | |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 8.66 | 17,274 | 149,593 | 82,726 | |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 5.76 | 19,929 | 114,791 | 105,071 | |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 5.76 | 5,071 | 29,209 | 100,000 | |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 50.00 | 20,000 | 1,000,000 | 129,601 | 149.6 K to 129.6 K (-13.37 %) |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 5.76 | 19,929 | 114,791 | 105,071 | |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 8.66 | 20,000 | 173,200 | 149,601 | 129.6 K to 149.6 K (+15.43 %) |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 50.00 | 20,000 | 1,000,000 | 129,601 | 149.6 K to 129.6 K (-13.37 %) |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 50.00 | 2,500 | 125,000 | 129,601 | 132.1 K to 129.6 K (-1.89 %) |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 8.66 | 20,000 | 173,200 | 149,601 | 129.6 K to 149.6 K (+15.43 %) |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 5.76 | 25,000 | 144,000 | 154,601 | 129.6 K to 154.6 K (+19.29 %) |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 50.00 | 2,500 | 125,000 | 129,601 | 132.1 K to 129.6 K (-1.89 %) |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 5.76 | 25,000 | 144,000 | 154,601 | 129.6 K to 154.6 K (+19.29 %) |